Product Information

POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1935 per EA under NDC 72888007605. Its NADAC has been published 149 times since Jan 10, 2024.

FDA first approved this application on Jul 25, 2022. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 20 MEQ TABLET

Potassium Chloride
$0.1935per EA

Strength

1500 mg/1

NDC

72888007605

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215725

FDA Approved

7/25/2022

TE Code

AB3

On Market Since

7/25/2022

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 149 times since Jan 10, 2024, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1935 per EA
All-time high$0.3125 (Apr 10, 2024)
All-time low$0.1290 (Nov 20, 2024)
52-week high$0.1935
52-week low$0.1593
Median price$0.1695
Average price$0.1891
Largest weekly change+66.3% (Aug 21, 2024)
Weeks tracked149
Tracking sinceJan 10, 2024

Price History

1W

0.0%

1M

+4.1%

3M

+21.5%

6M

+18.4%

1Y

+15.4%

3Y

N/A

5Y

N/A

All

-35.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Advagen Pharma Ltd., is $0.1935 per EA (NDC 72888007605), effective Nov 11, 2026.

How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 35.9%. It has been tracked across 149 weekly CMS publications since Jan 10, 2024.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?

Since Jan 10, 2024, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1290 (Nov 20, 2024) to a high of $0.3125 (Apr 10, 2024), with a median of $0.1695 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 20 MEQ TABLET, is $0.1437 per EA — about 26% below POTASSIUM CL ER 20 MEQ TABLET.

Who manufactures POTASSIUM CL ER 20 MEQ TABLET?

POTASSIUM CL ER 20 MEQ TABLET (NDC 72888007605) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.